Literature DB >> 15810069

Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.

Di-Peng Ou1, Lian-Yue Yang, Geng-Wen Huang, Yi-Ming Tao, Xiang Ding, Zhi-Gang Chang.   

Abstract

AIM: To comprehend the risk factors of recurrence of hepatocellular carcinoma (HCC) and its relationship with the infection patterns of hepatitis B virus (HBV).
METHODS: All materials of 270 cases of postoperative HCC were statistically analyzed by SPSS software. Recurrence and metastasis were classified into early (< or =2 years) and late phase (>2 years). Risk factors for recurrence and metastasis after surgery in each group were analyzed.
RESULTS: Out of 270 cases of HCC, 162 cases were followed up in which recurrence and metastasis occurred in 136 cases. There were a lot of risk factors related to recurrence and metastasis of HCC; risk factors contributing to early phase recurrence were serum AFP level, vascular invasion, incisal margin and operative transfusion, gross tumor classification and number of intrahepatic node to late phase recurrence. The HBV infective rate of recurrent HCC was 94.1%, in which "HBsAg, HBeAb, HbcAb" positive pattern reached 45.6%. The proportion of HBV infection in solitary large hepatocellular carcinoma (SLHCC) evidently decreased compared to nodular hepatocellular carcinoma (NHCC) (P<0.05).
CONCLUSION: The early and late recurrence and metastasis after hepatectomy of HCC were associated with different risk factors. The early recurrence may be mediated by vascular invasion and remnant lesion, the late recurrence by tumor's clinical pathology propert, as multicentric carcinogenesis or intrahepatic carcinoma de novo. HBV replication takes a great role in this process. From this study, we found that SLHCC has more satisfactory neoplasm biological behavior than NHCC.

Entities:  

Mesh:

Year:  2005        PMID: 15810069      PMCID: PMC4305772          DOI: 10.3748/wjg.v11.i14.2061

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview.

Authors:  Daniel Jaeck; Philippe Bachellier; Elie Oussoultzoglou; Jean-Christophe Weber; Philippe Wolf
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

2.  Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.

Authors:  N Théret; O Musso; B Turlin; D Lotrian; P Bioulac-Sage; J P Campion; K Boudjéma; B Clément
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody.

Authors:  J Pál; C Somogyi; A Szmolenszky A; G Szekeres; J Sípos; G Hegedüs; I Martzinovits; J Molnár; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; N Shimozawa; M Mihara; K Shimada; M Hiraguri; N Koide; W Adachi; J Amano
Journal:  J Am Coll Surg       Date:  2000-10       Impact factor: 6.113

5.  Chinese experience with hepatectomy for huge hepatocellular carcinoma.

Authors:  X P Chen; F Z Qiu; Z D Wu; B X Zhang
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

6.  Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.

Authors:  Teh-Ia Huo; Wing-Yu Lui; Jaw-Ching Wu; Yi-Hsiang Huang; Kuang-Liang King; Che-Chuan Loong; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

7.  High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Authors:  Kazuyuki Ohata; Keisuke Hamasaki; Kan Toriyama; Hiroki Ishikawa; Kazuhiko Nakao; Katsumi Eguchi
Journal:  J Gastroenterol Hepatol       Date:  2004-06       Impact factor: 4.029

8.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

9.  Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma.

Authors:  Chien-Hung Chen; Yang Yuan Chen; Gran-Hum Chen; Sien-Sing Yang; Huang-Shang Tang; Hsien Hong Lin; Deng-Yn Lin; Sing Kai Lo; Jeng-Ming Du; Ting-Tsung Chang; Shinn-Cherng Chen; Li-Ying Liao; Chung-Huang Kuo; Kwo-Chuan Lin; Dar-In Tai; Chi-Sin Changchien; Wen-Yu Chang; Jin-Chuan Sheu; Ding-Shinn Chen; Yun-Fan Liaw; Juei-Low Sung
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

10.  Major hepatectomy without blood transfusion: report of 51 cases.

Authors:  Jing-an Rui; Li Zhou; Fu-di Liu; Qing-fu Chu; Shao-bin Wang; Shu-guang Chen; Qiang Qu; Xue Wei; Kai Han; Ning Zhang; Hai-tao Zhao
Journal:  Chin Med J (Engl)       Date:  2004-05       Impact factor: 2.628

View more
  13 in total

1.  CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.

Authors:  Bin Chen; Shunli Shen; Jian Wu; Yunpeng Hua; Ming Kuang; Shaoqiang Li; Baogang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study.

Authors:  Mohamed Abdel Wahab; Ahmed Shehta; Hosam Hamed; Ayman El Nakeeb; Tarek Salah
Journal:  Eurasian J Med       Date:  2014-02

3.  Ultrasound-guided percutaneous microwave coagulation therapy with a "cooled-tip needle" for the treatment of hepatocellular carcinoma adjacent to the gallbladder.

Authors:  Wei-Dong Pan; Rong-Qin Zheng; Lin Nan; He-Ping Fang; Bo Liu; Zhao-Feng Tang; Mei-Hai Deng; Rui-Yun Xu
Journal:  Dig Dis Sci       Date:  2009-12-01       Impact factor: 3.199

Review 4.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal:  World J Hepatol       Date:  2014-06-27

Review 5.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.

Authors:  Dan-Hong Yang; Wei-Ping Wang; Qiang Zhang; Hong-Ying Pan; Yi-Cheng Huang; Jia-Jie Zhang
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

7.  Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.

Authors:  Zixiong Li; Ning Han; Xueying Ren; Yuanjing Zhang; Xiaoyuan Chu
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

8.  Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection.

Authors:  Myung Hee Yoon; Young Il Choi; Kwang Kuk Park; Dong Hoon Shin; Chung Han Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

9.  The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.

Authors:  Koichi Momiyama; Hidenari Nagai; Yu Ogino; Takanori Mukouzu; Daigo Matsui; Michio Kogame; Teppei Matsui; Noritaka Wakui; Mie Shinohara; Yoshinori Igarashi; Yasukiyo Sumino
Journal:  Clin Cancer Drugs       Date:  2015-02

10.  Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential.

Authors:  Hao Chen; Chun-Hui Yuan; Yi-Fei Yang; Chang-Qing Yin; Qing Guan; Fu-Bing Wang; Jian-Cheng Tu
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.